8 results
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
) - Vasculitis Management ... - ACR/VF 2021 Guidelines ... pulse IV GC with CYC ... #Treatment #ACR2021 ... #rheumatology
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
ANCA Vasculitis Management ... - ACR/VF 2021 Guidelines ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
ANCA Vasculitis Management ... - ACR/VF 2021 Guidelines ... Daily Oral GC CYC ... #Treatment #ACR2021 ... #rheumatology
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
→Activation of CD8 ... B-LNH), solid cancers ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary ... #rheumatology
ACA Colorectal Cancer Screening Guidelines

When to Screen?
When to Stop?
Family History

Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based
ACA Colorectal Cancer ... Screening Guidelines ... for Colorectal Cancer ... Indications #Tests #comparison ... #table #management
Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based tests:
 • FIT: 79% sensitivity, 94% specificity for CRC
for Colorectal Cancer ... Gastroenterology and Hepatology ... #Colorectal #Cancer ... Screening #Tests #comparison ... #table #management
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
life-threatening • Treatment ... Usual therapeutic management ... druginduced #lupus #sle #comparison ... #table #rheumatology ... #diagnosis #management
Hemophagocytic Lymphohistiocytosis (HLH)

High mortality without prompt recognition and management. HLH is a critical diagnostic consideration in
recognition and management ... it is often a cancer ... of NK cells and CD8 ... Treatment Approach ... #Hematology #HemeOnc